NM_024769.5:c.888C>T
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_024769.5(CLMP):c.888C>T(p.Ser296Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00564 in 1,614,078 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0038 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0058 ( 38 hom. )
Consequence
CLMP
NM_024769.5 synonymous
NM_024769.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.95
Genes affected
CLMP (HGNC:24039): (CXADR like membrane protein) This gene encodes a type I transmembrane protein that is localized to junctional complexes between endothelial and epithelial cells and may have a role in cell-cell adhesion. Expression of this gene in white adipose tissue is implicated in adipocyte maturation and development of obesity. This gene is also essential for normal intestinal development and mutations in the gene are associated with congenital short bowel syndrome. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 11-123073708-G-A is Benign according to our data. Variant chr11-123073708-G-A is described in ClinVar as [Benign]. Clinvar id is 791496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.95 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00379 (577/152368) while in subpopulation NFE AF= 0.00616 (419/68036). AF 95% confidence interval is 0.00567. There are 1 homozygotes in gnomad4. There are 271 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 38 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLMP | ENST00000448775.4 | c.888C>T | p.Ser296Ser | synonymous_variant | Exon 7 of 7 | 1 | NM_024769.5 | ENSP00000405577.2 | ||
CLMP | ENST00000527977.5 | n.710C>T | splice_region_variant, non_coding_transcript_exon_variant | Exon 5 of 5 | 3 | |||||
CLMP | ENST00000530371.5 | n.362C>T | non_coding_transcript_exon_variant | Exon 4 of 4 | 4 | |||||
ENSG00000288061 | ENST00000660892.2 | n.226+10195G>A | intron_variant | Intron 2 of 2 |
Frequencies
GnomAD3 genomes AF: 0.00378 AC: 576AN: 152250Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
576
AN:
152250
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00403 AC: 1012AN: 250858Hom.: 4 AF XY: 0.00415 AC XY: 563AN XY: 135538
GnomAD3 exomes
AF:
AC:
1012
AN:
250858
Hom.:
AF XY:
AC XY:
563
AN XY:
135538
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00583 AC: 8525AN: 1461710Hom.: 38 Cov.: 31 AF XY: 0.00567 AC XY: 4124AN XY: 727134
GnomAD4 exome
AF:
AC:
8525
AN:
1461710
Hom.:
Cov.:
31
AF XY:
AC XY:
4124
AN XY:
727134
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00379 AC: 577AN: 152368Hom.: 1 Cov.: 32 AF XY: 0.00364 AC XY: 271AN XY: 74514
GnomAD4 genome
AF:
AC:
577
AN:
152368
Hom.:
Cov.:
32
AF XY:
AC XY:
271
AN XY:
74514
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at